BrandPrinciples.com has been working on various market research reports pertaining to biotechnology which is there expertise and thus, concentrate only on this industry which is growing at a high speed. These unique research reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools.
This market research report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology, neurology, cardiology and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging. The market report provides global market analysis for biomarkers by prominent biomarker discovery technologies including imaging, genomics, proteomics, metabolomics, bioinformatics and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry / liquid chromatography and nanobiotechnology. Includes estimates and projections for the total global biomarkers market. Projections and estimates figure for geographic regions including United States, Europe, Japan, Asia-Pacific, Canada and rest of the world. A total of 402 companies are covered that are engaged in biomarkers R&D, discovery, testing, and supply of products and services.
Biomarkers discovery is fast gaining importance, especially in the field of medical research. Latest innovations in the area of transcriptomics, proteomics and metabolomics are driving the trend. Global biomarkers market is projected to reach about US$15 billion by 2010, with the United States retaining its dominance. Asia Pacific is the most vibrant region while Europe has some of the leading biomarkers companies. Cardiology is projected to be the fastest growing therapeutic area of biomarkers during the analysis period 2005-2010 with a CAGR of 22.3% followed by Neurology and Oncology. Bioinformatics is projected to be the fastest growing discovery technology for biomarkers for the analysis period 2005-2010 with a CAGR of 22.8% followed by Genomics and Metabolomics.
The latest trends and advancements in biotechnology have offered enormous expansion of genomics, proteomics and metabolomics fields by enabling cost effective DNA sequencing, mass spectroscopic antibody analyzing and evaluation of metabolic patterns of health by using NMR techniques. The introduction of these techniques to the field of biotechnology has led to the generation of incredible quantity of innovative biological and pharmaceutical information. The advancements in the field of information technology have enabled storing and retrieving of large quantities of data with minimal expenditure. The entry of mathematical applications into the field of biomarkers has helped in devising numerous mathematical and statistical equations to evaluate the stored medical and pharmaceutical data to provide error free biomarker development.
A free sample of report is available on request sent through their website.